Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
55,295,141
-
Share change
-
+7,664,963
-
Total reported value
-
$428,707,093
-
Put/Call ratio
-
147%
-
Price per share
-
$7.75
-
Number of holders
-
85
-
Value change
-
+$59,837,958
-
Number of buys
-
53
-
Number of sells
-
31
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2017
As of 30 Sep 2017,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,295,141 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., venBio Select Advisor LLC, ACUTA CAPITAL PARTNERS, LLC, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, Broadfin Capital, LLC, and FRAZIER MANAGEMENT LLC.
This page lists
85
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.